Diary - News
All news Imaxio and AJ Biologics announce the execution of a collaboration agreement to extend the commercialisation of Imaxio’s leptospirosis vaccine in Malaysia
Imaxio, a biotech company specialising in immunology, announces today the execution of a license agreement with AJ Biologics, a Malaysian company dedicated to vaccine manufacturing and commercialization, as part of the company’s strategy to extend the distribution of Imaxio’s leptospirosis vaccine in Malaysia.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree